Literature DB >> 26221994

Histologic Grade and Mitotic Index as Predictors of Microvascular Invasion in Hepatocellular Carcinoma.

Fernanda Maria Farage Osório1, Paula Vieira Teixeira Vidigal, Teresa Cristina Abreu Ferrari, Agnaldo Soares Lima, Gabriel Martin Lauar, Claudia Alves Couto.   

Abstract

OBJECTIVES: Microvascular invasion is a well-known risk factor for hepatocellular carcinoma recurrence and mortality after hepatic resection and liver transplant. We sought to determine the clinico-pathological predictive factors associated with microvascular invasion.
MATERIALS AND METHODS: We studied all patients who had undergone liver transplant because of hepatocellular carcinoma between July 2001 and December 2010 at our institution. Laboratory tests, clinical, and demographic data were obtained. Histopathological hematoxylin and eosin specimens were performed by a single liver pathologist.
RESULTS: During the study, 107 patients had LT because of HCC and they were selected for this investigation: 76 were men (71%) and 31 women (29%) (mean age, 56.8 ± 8.7 y). It was not possible to retrieve histologic samples from 5 patients; therefore, the final studied analysis was 102 individuals. Tumor recurrence rate was 12.9%. One-, three- and five-year overall survivals were 75.0%, 71.4%, and 67.5%. Mitotic index, histologic grade, tumor architecture, alpha-fetoprotein, and tumor fibrosis were associated with microvascular invasion on univariate analysis. Significant independent predictors of microvascular invasion on logistic regression analysis were histologic grade and mitotic index (P < .001; odds ratio, 3.16; 95% confidence interval, 1.525-4.156, and P = .046; odds ratio, 2.56; 95% confidence interval, 1.061-6.451).
CONCLUSIONS: Mitotic index and histologic grade are significant predictors of microvascular invasion. No other risk factor was identified in the logistic regression. As both pathological characteristics may be assessed by liver biopsy, these results highlight the importance of discussing pretransplant liver biopsy to access prognosis and define treatment modalities in the setting of liver transplant.

Entities:  

Mesh:

Year:  2015        PMID: 26221994     DOI: 10.6002/ect.2015.0045

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  4 in total

1.  Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.

Authors:  Hui Zhao; Chuang Chen; Xu Fu; Xiaopeng Yan; Wenjun Jia; Liang Mao; Huihan Jin; Yudong Qiu
Journal:  Oncotarget       Date:  2017-01-17

2.  The Value of TTPVI in Prediction of Microvascular Invasion in Hepatocellular Carcinoma.

Authors:  Tao Zhang; Gaurab Pandey; Lin Xu; Wen Chen; Liangrui Gu; Yijun Wu; Xiuwen Chen
Journal:  Cancer Manag Res       Date:  2020-06-02       Impact factor: 3.989

3.  Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma.

Authors:  Marcone Loiola Dos Santos; Andressa França; Antônio Carlos Melo Lima Filho; Rodrigo M Florentino; Paulo Henrique Diniz; Fernanda Oliveira Lemos; Carlos Alberto Xavier Gonçalves; Vitor Lima Coelho; Cristiano Xavier Lima; Giselle Foureaux; Michael H Nathanson; Paula Vieira Teixeira Vidigal; M Fátima Leite
Journal:  Oncol Lett       Date:  2021-11-25       Impact factor: 2.967

4.  Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma.

Authors:  Changbo Fu; Xuan Xu; Weijun Lu; Lei Nie; Tao Yin; Dongde Wu
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.